Good thing Kazia has an orally administered drug which can be mailed to participants in the study. One of the other companies in the GBM AGILE trial, Kintara, has an IV drug, so it would likely be more difficult to administer at a participant's home.
Ann: Kazia commences recruitment to GBM AGILE, page-15
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)